Literature DB >> 23382291

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

An Tang1, Justin Tan, Mark Sun, Gavin Hamilton, Mark Bydder, Tanya Wolfson, Anthony C Gamst, Michael Middleton, Elizabeth M Brunt, Rohit Loomba, Joel E Lavine, Jeffrey B Schwimmer, Claude B Sirlin.   

Abstract

PURPOSE: To evaluate the diagnostic performance of magnetic resonance (MR) imaging-estimated proton density fat fraction (PDFF) for assessing hepatic steatosis in nonalcoholic fatty liver disease (NAFLD) by using centrally scored histopathologic validation as the reference standard.
MATERIALS AND METHODS: This prospectively designed, cross-sectional, internal review board-approved, HIPAA-compliant study was conducted in 77 patients who had NAFLD and liver biopsy. MR imaging-PDFF was estimated from magnitude-based low flip angle multiecho gradient-recalled echo images after T2* correction and multifrequency fat modeling. Histopathologic scoring was obtained by consensus of the Nonalcoholic Steatohepatitis (NASH) Clinical Research Network Pathology Committee. Spearman correlation, additivity and variance stabilization for regression for exploring the effect of a number of potential confounders, and receiver operating characteristic analyses were performed.
RESULTS: Liver MR imaging-PDFF was systematically higher, with higher histologic steatosis grade (P < .001), and was significantly correlated with histologic steatosis grade (ρ = 0.69, P < .001). The correlation was not confounded by age, sex, lobular inflammation, hepatocellular ballooning, NASH diagnosis, fibrosis, or magnetic field strength (P = .65). Area under the receiver operating characteristic curves was 0.989 (95% confidence interval: 0.968, 1.000) for distinguishing patients with steatosis grade 0 (n = 5) from those with grade 1 or higher (n = 72), 0.825 (95% confidence interval: 0.734, 0.915) to distinguish those with grade 1 or lower (n = 31) from those with grade 2 or higher (n = 46), and 0.893 (95% confidence interval: 0.809, 0.977) to distinguish those with grade 2 or lower (n = 58) from those with grade 3 (n = 19).
CONCLUSION: MR imaging-PDFF showed promise for assessment of hepatic steatosis grade in patients with NAFLD. For validation, further studies with larger sample sizes are needed. © RSNA, 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23382291      PMCID: PMC3632805          DOI: 10.1148/radiol.12120896

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  46 in total

1.  Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease.

Authors:  R Pais; A Pascale; L Fedchuck; F Charlotte; T Poynard; V Ratziu
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-01       Impact factor: 2.947

2.  In vivo characterization of the liver fat ¹H MR spectrum.

Authors:  Gavin Hamilton; Takeshi Yokoo; Mark Bydder; Irene Cruite; Michael E Schroeder; Claude B Sirlin; Michael S Middleton
Journal:  NMR Biomed       Date:  2010-12-12       Impact factor: 4.044

3.  Liver methylene fraction by dual- and triple-echo gradient-echo imaging at 3.0T: Correlation with proton MR spectroscopy and estimation of robustness after SPIO administration.

Authors:  Boris Guiu; Jean-Michel Petit; Romaric Loffroy; Serge Aho; Douraied Ben Salem; David Masson; Isabelle Robin; Bruno Vergès; Patrick Hillon; Jean-Pierre Cercueil; Denis Krausé
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

4.  T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis.

Authors:  Catherine D G Hines; Alex Frydrychowicz; Gavin Hamilton; Dana L Tudorascu; Karl K Vigen; Huanzhou Yu; Charles A McKenzie; Claude B Sirlin; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

5.  Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Authors:  Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

6.  Percutaneous liver biopsy: patients' point of view.

Authors:  Luis Fernández-Salazar; Benito Velayos; Rocío Aller; Félix Lozano; José A Garrote; José M González
Journal:  Scand J Gastroenterol       Date:  2011-03-02       Impact factor: 2.423

7.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T.

Authors:  Takeshi Yokoo; Masoud Shiehmorteza; Gavin Hamilton; Tanya Wolfson; Michael E Schroeder; Michael S Middleton; Mark Bydder; Anthony C Gamst; Yuko Kono; Alexander Kuo; Heather M Patton; Santiago Horgan; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2011-01-06       Impact factor: 11.105

8.  Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.

Authors:  Jun Chen; Jayant A Talwalkar; Meng Yin; Kevin J Glaser; Schuyler O Sanderson; Richard L Ehman
Journal:  Radiology       Date:  2011-04-01       Impact factor: 11.105

9.  Assessment of liver fat quantification in the presence of iron.

Authors:  Mark Bydder; Masoud Shiehmorteza; Takeshi Yokoo; Sebastian Sugay; Michael S Middleton; Olivier Girard; Michael E Schroeder; Tanya Wolfson; Anthony Gamst; Claude Sirlin
Journal:  Magn Reson Imaging       Date:  2010-04-21       Impact factor: 2.546

10.  Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.

Authors:  Sina Meisamy; Catherine D G Hines; Gavin Hamilton; Claude B Sirlin; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

View more
  175 in total

1.  Effect of gadolinium on hepatic fat quantification using multi-echo reconstruction technique with T2* correction and estimation.

Authors:  Mingmei Ge; Jing Zhang; Bing Wu; Zhiqin Liu; Hai Song; Xiangfeng Meng; Xinhuai Wu
Journal:  Eur Radiol       Date:  2015-09-17       Impact factor: 5.315

2.  Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area.

Authors:  Kun Young Kim; Ji Soo Song; Stephan Kannengiesser; Young Min Han
Journal:  Radiol Med       Date:  2015-05-08       Impact factor: 3.469

Review 3.  Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Authors:  Mazen Noureddin; José M Mato; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-13

4.  Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.

Authors:  Kim Sivesgaard; Lars P Larsen; Michael Sørensen; Stine Kramer; Sven Schlander; Nerijus Amanavicius; Arindam Bharadwaz; Dennis Tønner Nielsen; Frank Viborg Mortensen; Erik Morre Pedersen
Journal:  Eur Radiol       Date:  2018-05-07       Impact factor: 5.315

5.  Altered In Vivo Lipid Fluxes and Cell Dynamics in Subcutaneous Adipose Tissues Are Associated With the Unfavorable Pattern of Fat Distribution in Obese Adolescent Girls.

Authors:  Jessica Nouws; Mark Fitch; Mariana Mata; Nicola Santoro; Brittany Galuppo; Romy Kursawe; Deepak Narayan; Alla Vash-Margita; Bridget Pierpont; Gerald I Shulman; Marc Hellerstein; Sonia Caprio
Journal:  Diabetes       Date:  2019-04-01       Impact factor: 9.461

6.  A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.

Authors:  Jeremy S Paige; Gregory S Bernstein; Elhamy Heba; Eduardo A C Costa; Marilia Fereirra; Tanya Wolfson; Anthony C Gamst; Mark A Valasek; Grace Y Lin; Aiguo Han; John W Erdman; William D O'Brien; Michael P Andre; Rohit Loomba; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2017-03-07       Impact factor: 3.959

7.  How bariatric surgery affects liver volume and fat density in NAFLD patients.

Authors:  Ran B Luo; Toshiaki Suzuki; Jonathan C Hooker; Yesenia Covarrubias; Alexandra Schlein; Shanglei Liu; Jeffrey B Schwimmer; Scott B Reeder; Luke M Funk; Jacob A Greenberg; Guilherme M Campos; Bryan J Sandler; Santiago Horgan; Claude B Sirlin; Garth R Jacobsen
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

8.  MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.

Authors:  Guido Ligabue; Giulia Besutti; Riccardo Scaglioni; Chiara Stentarelli; Giovanni Guaraldi
Journal:  Quant Imaging Med Surg       Date:  2013-08

9.  Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.

Authors:  Jennifer L Rehm; Peter M Wolfgram; Diego Hernando; Jens C Eickhoff; David B Allen; Scott B Reeder
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

Review 10.  Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.

Authors:  Cristiane Valle Tovo; Angelo Zambam de Mattos; Gabriela Perdomo Coral; Fernanda Schild Branco; Eiji Suwa; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.